Table 4.
ACR 1997 criteria | SLICC 2012 criteria | EULAR/ACR 2019 criteria | |
---|---|---|---|
Derivation | |||
Sensitivity [95% CI] | 0.85 [0.81-0.88] | 0.97 [0.95-0.98] | 0.98 [0.97-0.99] |
Specificity [95% CI] | 0.95 [0.93-0.97] | 0.90 [0.87-0.92] | 0.96 [0.95-0.98] |
Combined [95% CI] | 1.80 [1.76-1.83] | 1.87 [1.84-1.90] | 1.94 [1.92-1.96] |
Validation | |||
Sensitivity [95% CI] | 0.83 [0.80-0.85] | 0.97 [0.95-0.98] | 0.96 [0.95-0.98] |
Specificity [95% CI] | 0.93 [0.91-0.95] | 0.84 [0.80-0.87] | 0.93 [0.91-0.95] |
Combined [95% CI] | 1.76 [1.73-1.80] | 1.80 [1.77-1.84] | 1.90 [1.87-1.92] |
ACR American College of Rheumatology, SLICC Systemic Lupus International Collaborating Clinics, CI Confidence Intervals